Stereotactic body radiotherapy (SBRT) of patients with oligometastatic urothelial cancer (UC): A single institution experience

被引:0
|
作者
Jawdat, F. [1 ]
Svedman, F. Costa [1 ]
Holmsten, K. [2 ]
Grozman, V. [3 ]
Alm, D. [1 ]
Hailom, W. S. [1 ]
Ullen, A. [1 ]
机构
[1] Karolinska Univ Hosp Solna, Dept Oncol, Solna, Sweden
[2] Karolinska Inst, Oncol & Pathol, Stockholm, Sweden
[3] Karolinska Univ Hosp Solna, Sect Thorac Radiol, Dept Imaging & Physiol, Solna, Sweden
基金
芬兰科学院;
关键词
D O I
10.1016/j.annonc.2023.09.1032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2383P
引用
收藏
页码:S1213 / S1214
页数:2
相关论文
共 50 条
  • [41] Metastasis-Directed Stereotactic Body Radiation Therapy for Oligometastatic Colorectal Cancer: A Single Institution Experience
    Jethwa, K. R.
    Jang, S.
    Olivier, K.
    Park, S. S.
    Merrell, K. W.
    Martenson, J. A.
    Neben-Wittich, M. A.
    Roberts, K. W.
    Arnett, A. L. H.
    Hubbard, J. M.
    Whitaker, T. J.
    Harmsen, W. S.
    Waltman, L. A.
    Kipp, B. R.
    Grothey, A.
    Haddock, M. G.
    Hallemeier, C. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E7 - E8
  • [42] Stereotactic body radiation therapy (SBRT) for HCC treatment: a single institution experience
    Mazzarelli, C.
    Sibio, D.
    Cesarini, L.
    Patel, M. T.
    De Mattia, C.
    Vigano, R.
    Perricone, G.
    Aprile, F.
    Cucco, M.
    Becchetti, C.
    Costantino, D.
    Fazio, M.
    Bencardino, K.
    Villa, F.
    Sgrazzutti, C.
    Vicentin, I.
    Palazzi, M. F.
    Belli, L.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S93 - S94
  • [43] Stereotactic body radiotherapy for lung metastases from colorectal cancer: a single institution experience
    Wegner, Rodney E.
    Ahmed, Nissar
    Hasan, Shaakir
    McCormick, James
    Kirichenko, Alexander, V
    Colonias, Athanasios
    COLORECTAL CANCER, 2018, 7 (03)
  • [44] Stereotactic Body Radiotherapy (SBRT): Are we improving? Trends from a single Brazilian institution
    Moraes, F. Y.
    Bonifacio, L. A.
    Marta, G. N.
    Hanna, S. A.
    Carvalho, H. A.
    Arruda, F. F.
    Siqueria, G. S. M.
    Correa, S. F. M.
    Silva, J. L. F.
    Abreu, C. E. C. V.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S238 - S238
  • [45] STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR OLIGOMETASTATIC TRANSITIONAL CELL CARCINOMA: SINGLE INSITUTION SERIES OF 11 PATIENTS/19 LESIONS
    Augugliaro, Matteo
    Marvaso, Giulia
    Zerini, Dario
    Riva, Giulia
    Rondi, Elena
    Vigorito, Sabrina
    Comi, Stefania
    De Cobelli, Ottavio
    Orecchia, Roberto
    Jereczek-Fossa, Barbara Alicja
    ANTICANCER RESEARCH, 2018, 38 (04) : 2571 - 2572
  • [46] Stereotactic body radiotherapy for oligometastatic and oligoprogression patients
    De la Pinta Alonso, C.
    Vallejo Ocana, C.
    Hernanz De Lucas, R.
    Martin Martin, M.
    Fernandez-Lizarbe, E.
    Martin Sanchez, M.
    Dominguez Rullan, J.
    Munoz Miguelaez, T.
    Lopez Campos, F.
    Hervas Moron, A.
    Sancho Garcia, S.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S913 - S913
  • [47] Stereotactic body radiotherapy (SBRT) for liver metastasis of colorectal and anal cancer patients: Clinical outcomes of a single centre experience
    Martin-Cullell, B.
    Paez, D.
    Virgili, A.
    Sebio, A.
    Pelegrin, F.
    Mirallas, O.
    Balart, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S116 - S116
  • [48] Stereotactic Radiotherapy for Pancreatic Cancer: A Single-Institution Experience
    Glicksman, Rachel M.
    Chung, Hans
    Myrehaug, Sten
    Erler, Darby
    Korol, Renee
    Karotki, Aliaksandr
    Taggar, Aman
    Ung, Yee C.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (09)
  • [49] Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
    Rosanna Yeung
    Jeremy Hamm
    Mitchell Liu
    Devin Schellenberg
    Radiation Oncology, 12
  • [50] Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
    Yeung, Rosanna
    Hamm, Jeremy
    Liu, Mitchell
    Schellenberg, Devin
    RADIATION ONCOLOGY, 2017, 12